|Title:||Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma||Authors:||CHIUN HSU
Chen, Mary M
|Keywords:||Breast carcinoma | Chemotherapy naïve | Cisplatin | Paclitaxel||Issue Date:||15-Nov-2002||Journal Volume:||95||Journal Issue:||10||Source:||Cancer||Abstract:||
Both paclitaxel and cisplatin are active as second-line chemotherapy for patients with breast carcinoma. A synergistic cytotoxicity of these two drugs has been demonstrated in vitro. This study sought to determine the efficacy of combining these two drugs in the treatment of chemotherapy-naïve patients with breast carcinoma.
|Appears in Collections:||腫瘤醫學研究所|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.